Importantly, genetic ablation of Trem2 in obese mice suppressed the downstream molecular LAM program, resulting in adipocyte hypertrophy, systemic hypercholesterolemia, body fat accumulation and glucose intolerance [35], providing a new perspective on the function of Trem2 in metabolic disease. This evidence concerns the gene TREM2 and Other metabolic disease.